Analgesics
Antiandrogens
Antihistamines
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Results
Abstract
All zinc studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchZincZinc (more..)
Melatonin Meta
Metformin Meta
Antihistamines Meta
Azvudine Meta Molnupiravir Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   

Efficacy and Safety of Aspirin, Promethazine, and Micronutrients for Rapid Clinical Recovery in Mild to Moderate COVID-19 Patients: A Randomized Controlled Clinical Trial

May 2022  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Recovery, dyspnea 89% Improvement Relative Risk Recovery, anosmia 95% Recovery, fatigue 94% Recovery, myalgia -388% Recovery, headache -194% Recovery, cough 9% Zinc  Kumar et al.  EARLY TREATMENT  RCT Is early treatment with zinc + combined treatments beneficial for COVID-19? RCT 192 patients in India (December 2021 - February 2022) Improved recovery with zinc + combined treatments (not stat. sig., p=0.053) c19early.org Kumar et al., Cureus, May 2022 Favorszinc Favorscontrol 0 0.5 1 1.5 2+
Zinc for COVID-19
2nd treatment shown to reduce risk in July 2020
 
*, now with p = 0.00000032 from 46 studies, recognized in 17 countries.
No treatment is 100% effective. Protocols combine treatments. * >10% efficacy, ≥3 studies.
4,800+ studies for 98 treatments. c19early.org
RCT 260 patients in India, 130 treated with aspirin, promethazine, vitamin C, D, B3, zinc, and selenium, showing faster recovery with treatment. There was no hospitalization, ICU admission, or supplemental oxygen requirements in either group.
Study covers aspirin, vitamin C, zinc, and vitamin D.
risk of no recovery, 89.2% lower, RR 0.11, p = 0.05, treatment 0 of 99 (0.0%), control 4 of 93 (4.3%), NNT 23, relative risk is not 0 because of continuity correction due to zero events (with reciprocal of the contrasting arm), day 10, dyspnea.
risk of no recovery, 95.4% lower, RR 0.05, p < 0.001, treatment 0 of 99 (0.0%), control 10 of 93 (10.8%), NNT 9.3, relative risk is not 0 because of continuity correction due to zero events (with reciprocal of the contrasting arm), day 10, anosmia.
risk of no recovery, 94.3% lower, RR 0.06, p = 0.003, treatment 0 of 99 (0.0%), control 8 of 93 (8.6%), NNT 12, relative risk is not 0 because of continuity correction due to zero events (with reciprocal of the contrasting arm), day 10, fatigue.
risk of no recovery, 387.9% higher, RR 4.88, p = 0.50, treatment 2 of 99 (2.0%), control 0 of 93 (0.0%), continuity correction due to zero event (with reciprocal of the contrasting arm), day 10, myalgia.
risk of no recovery, 193.9% higher, RR 2.94, p = 1.00, treatment 1 of 99 (1.0%), control 0 of 93 (0.0%), continuity correction due to zero event (with reciprocal of the contrasting arm), day 10, headache.
risk of no recovery, 8.5% lower, RR 0.91, p = 0.66, treatment 37 of 99 (37.4%), control 38 of 93 (40.9%), NNT 29, day 10, cough.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Kumar et al., 30 May 2022, Randomized Controlled Trial, India, peer-reviewed, mean age 36.0, 8 authors, study period December 2021 - February 2022, this trial uses multiple treatments in the treatment arm (combined with aspirin, promethazine, vitamin C, D, B3, and selenium) - results of individual treatments may vary, trial CTRI/2021/06/034254. Contact: vgvclinical@gmail.com.
This PaperZincAll
Efficacy and Safety of Aspirin, Promethazine, and Micronutrients for Rapid Clinical Recovery in Mild to Moderate COVID-19 Patients: A Randomized Controlled Clinical Trial
Dr. G Sunil Kumar, Dr. Atul Vadgaonkar, Dr. Srilata Purunaik, Rohit Shelatkar, Vidyadhar G Vaidya, Dr. Gayatri Ganu, Dr. Aditya Vadgaonkar, Shashank Joshi
Cureus, doi:10.7759/cureus.25467
Introduction In the present study, the combination of two tablets, one with Aspirin and Promethazine and the other with vitamin D3, C, and B3 along with zinc and selenium supplementation was proposed as an intervention (APMV2020). The ingredients in the formulation represent a precise, tailored therapy for the symptoms of COVID-19, combined with natural constituents to help the body itself build immunity to recover from infection. The present study was conducted to clinically validate the safety and efficacy of the APMV2020 tablets. Trial design The present trial is a randomized, multicentric, controlled clinical trial involving 260 mild to moderate COVID-19 patients. The treatment duration was of 10 days. Methodology The subjects were randomized to receive either the control intervention (clinical management protocol for COVID-19 advocated by the Indian Council of Medical Research (ICMR) or the test intervention (treatment with APMV2020 tablets along with the standard control treatment. The assessment days were baseline, days five and 10. Results APMV2020 significantly (<0.05) improved symptoms of COVID-19 like cough, myalgia, headache, and anosmia as compared to the control group. APMV2020 treatment also reduced inflammatory markers like lactate dehydrogenase (LDH), ferritin, and C-reactive protein (CRP). Conclusion APMV2020 can prove as a good candidate to be integrated into the COVID-19 management protocol. As it can offer speedy clinical recovery to reduce the burden on healthcare infrastructure, second, the combination shows significant anti-inflammatory potential to improve prognosis, and lastly, the immunomodulatory properties offer long-term protection that can help in combating long COVID symptoms and complications.
Additional Information Disclosures Human subjects: Consent was obtained or waived by all participants in this study. Royal Pune Independent Ethics Committee, Pune, Maharashtra. issued approval CTRI/2021/06/034254. The study was approved by the Institutional ethics committee, Lokmanya Medical Research Centre, and Royal Pune Independent Ethics Committee and was registered with the Clinical Trial Registry of India (CTRI/2021/06/034254). Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of
References
Alam, Bhuiyan, Emon, Hasan, Prospects of nutritional interventions in the care of COVID-19 patients, Heliyon, doi:10.1016/j.heliyon.2021.e06285
Banoun, Evolution of SARS-CoV-2: review of mutations, role of the host immune system, Nephron, doi:10.1159/000515417
Becerra-Flores, Cardozo, SARS-CoV-2 viral spike G614 mutation exhibits higher case fatality rate, Int J Clin Pract, doi:10.1111/ijcp.13525
Calder, Nutrition and immunity: lessons for COVID-19, Nutr Diabetes, doi:10.1038/s41387-021-00165-0
Cantisani, Ricci, Grieco, Paolino, Faina et al., Topical promethazine side effects: our experience and review of the literature, Biomed Res Int, doi:10.1155/2013/151509
Carr, Rowe, The emerging role of vitamin C in the prevention and treatment of COVID-19, Nutrients, doi:10.3390/nu12113286
Chinni, El-Khoury, Perera, Zinc supplementation as an adjunct therapy for COVID-19: challenges and opportunities, Br J Clin Pharmacol, doi:10.1111/bcp.14826
Chow, Khanna, Kethireddy, Aspirin use is associated with decreased mechanical ventilation, intensive care unit admission, and in-hospital mortality in hospitalized patients with coronavirus disease 2019, Anesth Analg, doi:10.1213/ANE.0000000000005292
Khatiwada, Subedi, A mechanistic link between selenium and coronavirus disease 2019 (COVID-19), Curr Nutr Rep, doi:10.1007/s13668-021-00354-4
Kumar, None, Cureus, doi:10.7759/cureus.2546710of10
Lotfi, Akbarzadeh-Khiavi, Lotfi, Micronutrient therapy and effective immune response: a promising approach for management of COVID-19, Infection, doi:10.1007/s15010-021-01644-3
Mahmud, Rahman, Rassel, Monayem, Sayeed et al., Post-COVID-19 syndrome among symptomatic COVID-19 patients: a prospective cohort study in a tertiary care center of Bangladesh, PLoS One, doi:10.1371/journal.pone.0249644
Name, Souza, Vasconcelos, Prado, Pereira et al., perspectives for COVID-19 with a focus on physical tissue barrier integrity, Front Nutr, doi:10.3389/fnut.2020.606398
Osuchowski, Winkler, Skirecki, It can be concluded that APMV2020 treatment for COVID-19 patients provides advantages over the standard of care treatment alone. There was a faster recovery of subjects from COVID-19 symptoms, along with a significant reduction in inflammatory markers like LDH ferritin, and CRP. This study serves as preliminary evidence for further research using aspirin, promethazine, vitamin D, C, and micronutrient therapy as an intervention in the management of long COVID symptoms, Lancet Respir Med, doi:10.1016/S2213-2600(21)00218-6
Shakoor, Feehan, Mikkelsen, Be well: a potential role for vitamin B in COVID-19, Maturitas, doi:10.1016/j.maturitas.2020.08.007
Tay, Poh, Rénia, Macary, Ng, The trinity of COVID-19: immunity, inflammation and intervention, Nat Rev Immunol, doi:10.1038/s41577-020-0311-8
Wijaya, Andhika, Huang, Purwiga, Budiman, The effects of aspirin on the outcome of COVID-19: a systematic review and meta-analysis, Clin Epidemiol Glob Health, doi:10.1016/j.cegh.2021.100883
{ 'indexed': {'date-parts': [[2022, 5, 30]], 'date-time': '2022-05-30T07:41:06Z', 'timestamp': 1653896466960}, 'reference-count': 16, 'publisher': 'Cureus, Inc.', 'content-domain': {'domain': [], 'crossmark-restriction': False}, 'published-print': {'date-parts': [[2022, 5, 30]]}, 'DOI': '10.7759/cureus.25467', 'type': 'journal-article', 'created': {'date-parts': [[2022, 5, 30]], 'date-time': '2022-05-30T07:16:46Z', 'timestamp': 1653895006000}, 'source': 'Crossref', 'is-referenced-by-count': 0, 'title': 'Efficacy and Safety of Aspirin, Promethazine, and Micronutrients for Rapid Clinical Recovery in ' 'Mild to Moderate COVID-19 Patients: A Randomized Controlled Clinical Trial', 'prefix': '10.7759', 'author': [ {'given': 'Dr. G. Sunil', 'family': 'Kumar', 'sequence': 'first', 'affiliation': []}, {'given': 'Dr.Atul', 'family': 'Vadgaonkar', 'sequence': 'additional', 'affiliation': []}, {'given': 'Dr. Srilata', 'family': 'Purunaik', 'sequence': 'additional', 'affiliation': []}, {'given': 'Rohit', 'family': 'Shelatkar', 'sequence': 'additional', 'affiliation': []}, {'given': 'Vidyadhar G', 'family': 'Vaidya', 'sequence': 'additional', 'affiliation': []}, {'given': 'Dr. Gayatri', 'family': 'Ganu', 'sequence': 'additional', 'affiliation': []}, {'given': 'Dr. Aditya', 'family': 'Vadgaonkar', 'sequence': 'additional', 'affiliation': []}, {'given': 'Shashank', 'family': 'Joshi', 'sequence': 'additional', 'affiliation': []}], 'member': '4492', 'reference': [ { 'key': 'ref1', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/S2213-2600(21)00218-6', 'article-title': 'The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a ' 'new disease entity', 'volume': '9', 'author': 'Osuchowski MF', 'year': '2021', 'unstructured': 'Osuchowski MF, Winkler MS, Skirecki T, et al.. The COVID-19 puzzle: ' 'deciphering pathophysiology and phenotypes of a new disease entity. ' 'Lancet Respir Med. 2021, 9:622-42. 10.1016/S2213-2600(21)00218-6', 'journal-title': 'Lancet Respir Med'}, { 'key': 'ref2', 'doi-asserted-by': 'publisher', 'DOI': '10.1111/ijcp.13525', 'article-title': 'SARS-CoV-2 viral spike G614 mutation exhibits higher case fatality rate', 'volume': '74', 'author': 'Becerra-Flores M', 'year': '2020', 'unstructured': 'Becerra-Flores M, Cardozo T. SARS-CoV-2 viral spike G614 mutation ' 'exhibits higher case fatality rate. Int J Clin Pract. 2020, 74:e13525. ' '10.1111/ijcp.13525', 'journal-title': 'Int J Clin Pract'}, { 'key': 'ref3', 'doi-asserted-by': 'publisher', 'DOI': '10.3390/nu12113286', 'article-title': 'The emerging role of vitamin C in the prevention and treatment of ' 'COVID-19', 'volume': '12', 'author': 'Carr AC', 'year': '2020', 'unstructured': 'Carr AC, Rowe S. The emerging role of vitamin C in the prevention and ' 'treatment of COVID-19. Nutrients. 2020, 12:10.3390/nu12113286', 'journal-title': 'Nutrients'}, { 'key': 'ref4', 'doi-asserted-by': 'publisher', 'DOI': '10.1159/000515417', 'article-title': 'Evolution of SARS-CoV-2: review of mutations, role of the host immune ' 'system', 'volume': '145', 'author': 'Banoun H', 'year': '2021', 'unstructured': 'Banoun H. Evolution of SARS-CoV-2: review of mutations, role of the host ' 'immune system. Nephron. 2021, 145:392-403. 10.1159/000515417', 'journal-title': 'Nephron'}, { 'key': 'ref5', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.cegh.2021.100883', 'article-title': 'The effects of aspirin on the outcome of COVID-19: a systematic review ' 'and meta-analysis', 'volume': '12', 'author': 'Wijaya I', 'year': '2021', 'unstructured': 'Wijaya I, Andhika R, Huang I, Purwiga A, Budiman KY. The effects of ' 'aspirin on the outcome of COVID-19: a systematic review and ' 'meta-analysis. Clin Epidemiol Glob Health. 2021, 12:100883. ' '10.1016/j.cegh.2021.100883', 'journal-title': 'Clin Epidemiol Glob Health'}, { 'key': 'ref6', 'doi-asserted-by': 'publisher', 'DOI': '10.1213/ANE.0000000000005292', 'article-title': 'Aspirin use is associated with decreased mechanical ventilation, ' 'intensive care unit admission, and in-hospital mortality in ' 'hospitalized patients with coronavirus disease 2019', 'volume': '132', 'author': 'Chow JH', 'year': '2021', 'unstructured': 'Chow JH, Khanna AK, Kethireddy S, et al.. Aspirin use is associated with ' 'decreased mechanical ventilation, intensive care unit admission, and ' 'in-hospital mortality in hospitalized patients with coronavirus disease ' '2019. Anesth Analg. 2021, 132:930-41. 10.1213/ANE.0000000000005292', 'journal-title': 'Anesth Analg'}, { 'key': 'ref7', 'doi-asserted-by': 'publisher', 'DOI': '10.1155/2013/151509', 'article-title': 'Topical promethazine side effects: our experience and review of the ' 'literature', 'volume': '2013', 'author': 'Cantisani C', 'year': '2013', 'unstructured': 'Cantisani C, Ricci S, Grieco T, Paolino G, Faina V, Silvestri E, ' 'Calvieri S. Topical promethazine side effects: our experience and review ' 'of the literature. Biomed Res Int. 2013, 2013:151509. ' '10.1155/2013/151509', 'journal-title': 'Biomed Res Int'}, { 'key': 'ref8', 'doi-asserted-by': 'publisher', 'DOI': '10.1111/bcp.14826', 'article-title': 'Zinc supplementation as an adjunct therapy for COVID-19: challenges and ' 'opportunities', 'volume': '87', 'author': 'Chinni V', 'year': '2021', 'unstructured': 'Chinni V, El-Khoury J, Perera M, et al.. Zinc supplementation as an ' 'adjunct therapy for COVID-19: challenges and opportunities. Br J Clin ' 'Pharmacol. 2021, 87:3737-46. 10.1111/bcp.14826', 'journal-title': 'Br J Clin Pharmacol'}, { 'key': 'ref9', 'doi-asserted-by': 'publisher', 'DOI': '10.1371/journal.pone.0249644', 'article-title': 'Post-COVID-19 syndrome among symptomatic COVID-19 patients: a ' 'prospective cohort study in a tertiary care center of Bangladesh', 'volume': '16', 'author': 'Mahmud R', 'year': '2021', 'unstructured': 'Mahmud R, Rahman MM, Rassel MA, Monayem FB, Sayeed SK, Islam MS, Islam ' 'MM. Post-COVID-19 syndrome among symptomatic COVID-19 patients: a ' 'prospective cohort study in a tertiary care center of Bangladesh. PLoS ' 'One. 2021, 16:e0249644. 10.1371/journal.pone.0249644', 'journal-title': 'PLoS One'}, { 'key': 'ref10', 'doi-asserted-by': 'publisher', 'DOI': '10.1038/s41577-020-0311-8', 'article-title': 'The trinity of COVID-19: immunity, inflammation and intervention', 'volume': '20', 'author': 'Tay MZ', 'year': '2020', 'unstructured': 'Tay MZ, Poh CM, Rénia L, MacAry PA, Ng LF. The trinity of COVID-19: ' 'immunity, inflammation and intervention. Nat Rev Immunol. 2020, ' '20:363-74. 10.1038/s41577-020-0311-8', 'journal-title': 'Nat Rev Immunol'}, { 'key': 'ref11', 'doi-asserted-by': 'publisher', 'DOI': '10.3389/fnut.2020.606398', 'article-title': 'Zinc, vitamin D and vitamin C: perspectives for COVID-19 with a focus ' 'on physical tissue barrier integrity', 'volume': '7', 'author': 'Name JJ', 'year': '2020', 'unstructured': 'Name JJ, Souza AC, Vasconcelos AR, Prado PS, Pereira CP. Zinc, vitamin D ' 'and vitamin C: perspectives for COVID-19 with a focus on physical tissue ' 'barrier integrity. Front Nutr. 2020, 7:606398. 10.3389/fnut.2020.606398', 'journal-title': 'Front Nutr'}, { 'key': 'ref12', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.maturitas.2020.08.007', 'article-title': 'Be well: a potential role for vitamin B in COVID-19', 'volume': '144', 'author': 'Shakoor H', 'year': '2021', 'unstructured': 'Shakoor H, Feehan J, Mikkelsen K, et al.. Be well: a potential role for ' 'vitamin B in COVID-19. Maturitas. 2021, 144:108-11. ' '10.1016/j.maturitas.2020.08.007', 'journal-title': 'Maturitas'}, { 'key': 'ref13', 'doi-asserted-by': 'publisher', 'DOI': '10.1007/s13668-021-00354-4', 'article-title': 'A mechanistic link between selenium and coronavirus disease 2019 ' '(COVID-19)', 'volume': '10', 'author': 'Khatiwada S', 'year': '2021', 'unstructured': 'Khatiwada S, Subedi A. A mechanistic link between selenium and ' 'coronavirus disease 2019 (COVID-19). Curr Nutr Rep. 2021, 10:125-36. ' '10.1007/s13668-021-00354-4', 'journal-title': 'Curr Nutr Rep'}, { 'key': 'ref14', 'doi-asserted-by': 'publisher', 'DOI': '10.1007/s15010-021-01644-3', 'article-title': 'Micronutrient therapy and effective immune response: a promising ' 'approach for management of COVID-19', 'volume': '49', 'author': 'Lotfi F', 'year': '2021', 'unstructured': 'Lotfi F, Akbarzadeh-Khiavi M, Lotfi Z, et al.. Micronutrient therapy and ' 'effective immune response: a promising approach for management of ' 'COVID-19. Infection. 2021, 49:1133-47. 10.1007/s15010-021-01644-3', 'journal-title': 'Infection'}, { 'key': 'ref15', 'doi-asserted-by': 'publisher', 'DOI': '10.1038/s41387-021-00165-0', 'article-title': 'Nutrition and immunity: lessons for COVID-19', 'volume': '11', 'author': 'Calder PC', 'year': '2021', 'unstructured': 'Calder PC. Nutrition and immunity: lessons for COVID-19. Nutr Diabetes. ' '2021, 11:19. 10.1038/s41387-021-00165-0', 'journal-title': 'Nutr Diabetes'}, { 'key': 'ref16', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.heliyon.2021.e06285', 'article-title': 'Prospects of nutritional interventions in the care of COVID-19 patients', 'volume': '7', 'author': 'Alam S', 'year': '2021', 'unstructured': 'Alam S, Bhuiyan FR, Emon TH, Hasan M. Prospects of nutritional ' 'interventions in the care of COVID-19 patients. Heliyon. 2021, 7:e06285. ' '10.1016/j.heliyon.2021.e06285', 'journal-title': 'Heliyon'}], 'container-title': 'Cureus', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://www.cureus.com/articles/96829-efficacy-and-safety-of-aspirin-promethazine-and-micronutrients-for-rapid-clinical-recovery-in-mild-to-moderate-covid-19-patients-a-randomized-controlled-clinical-trial', 'content-type': 'unspecified', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'deposited': { 'date-parts': [[2022, 5, 30]], 'date-time': '2022-05-30T07:16:48Z', 'timestamp': 1653895008000}, 'score': 1, 'resource': { 'primary': { 'URL': 'https://www.cureus.com/articles/96829-efficacy-and-safety-of-aspirin-promethazine-and-micronutrients-for-rapid-clinical-recovery-in-mild-to-moderate-covid-19-patients-a-randomized-controlled-clinical-trial'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2022, 5, 30]]}, 'references-count': 16, 'URL': 'http://dx.doi.org/10.7759/cureus.25467', 'relation': {}, 'ISSN': ['2168-8184'], 'subject': ['Aerospace Engineering'], 'published': {'date-parts': [[2022, 5, 30]]}}
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit